Xueren Gao

678 total citations
40 papers, 557 citations indexed

About

Xueren Gao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xueren Gao has authored 40 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 18 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Xueren Gao's work include Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (9 papers) and MicroRNA in disease regulation (7 papers). Xueren Gao is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (9 papers) and MicroRNA in disease regulation (7 papers). Xueren Gao collaborates with scholars based in China and Bangladesh. Xueren Gao's co-authors include Zhansheng Zhu, Shulong Zhang, Yuzhen Gao, Jianqiong Zhang, Dong Dong, Mingxi Wang, Jiaojiao Yang, Yuting Jiang, Shasha Jia and Jiao Wan and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Xueren Gao

38 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xueren Gao China 16 332 231 117 99 51 40 557
Luis Almonacid Spain 9 288 0.9× 247 1.1× 165 1.4× 76 0.8× 26 0.5× 10 530
Conny Blumert Germany 7 469 1.4× 398 1.7× 134 1.1× 117 1.2× 56 1.1× 16 656
Dawei Bu United States 12 278 0.8× 125 0.5× 51 0.4× 147 1.5× 29 0.6× 24 486
Kayo Fujisawa Japan 12 243 0.7× 72 0.3× 104 0.9× 143 1.4× 31 0.6× 18 508
Jun Chi China 9 388 1.2× 322 1.4× 77 0.7× 59 0.6× 36 0.7× 20 621
Parvathi Ranganathan United States 14 538 1.6× 189 0.8× 156 1.3× 107 1.1× 28 0.5× 37 764
Hongting Lu China 14 390 1.2× 267 1.2× 226 1.9× 151 1.5× 47 0.9× 39 752
Zhengyuan Yu China 15 476 1.4× 331 1.4× 104 0.9× 198 2.0× 42 0.8× 35 718
Wyne Lee United States 3 185 0.6× 273 1.2× 402 3.4× 83 0.8× 32 0.6× 5 631
Sven Kroening Germany 12 427 1.3× 207 0.9× 77 0.7× 62 0.6× 69 1.4× 12 604

Countries citing papers authored by Xueren Gao

Since Specialization
Citations

This map shows the geographic impact of Xueren Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueren Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueren Gao more than expected).

Fields of papers citing papers by Xueren Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueren Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueren Gao. The network helps show where Xueren Gao may publish in the future.

Co-authorship network of co-authors of Xueren Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Xueren Gao. A scholar is included among the top collaborators of Xueren Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueren Gao. Xueren Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Shulong, et al.. (2023). TP73-AS1 rs3737589 Polymorphism is Associated With the Clinical Stage of Colorectal Cancer. Evidence-based Complementary and Alternative Medicine. 2023(1). 3931875–3931875. 2 indexed citations
2.
Gao, Xueren, Shulong Zhang, & Xiaoting Wang. (2022). HAND2-AS1 rs2276941 Polymorphism Affecting the Binding of hsa-miR-1275 Is Associated with the Risk of Colorectal Cancer. DNA and Cell Biology. 41(6). 600–605. 4 indexed citations
3.
Gao, Xueren, et al.. (2021). The Association of MEG3 Gene rs7158663 Polymorphism With Cancer Susceptibility. Frontiers in Oncology. 11. 796774–796774. 14 indexed citations
4.
Gao, Xueren & Jiaojiao Yang. (2020). Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer. DNA and Cell Biology. 39(4). 690–699. 24 indexed citations
5.
Wang, Jie, Ying Zhang, Jing Xia, et al.. (2018). Neuronal PirB Upregulated in Cerebral Ischemia Acts as an Attractive Theranostic Target for Ischemic Stroke. Journal of the American Heart Association. 7(3). 21 indexed citations
6.
Xia, Jing, Ying Zhang, Huanhuan Zhao, et al.. (2017). Non-Invasive Monitoring of CNS MHC-I Molecules in Ischemic Stroke Mice. Theranostics. 7(11). 2837–2848. 15 indexed citations
7.
Gao, Xueren, et al.. (2016). TCF21genetic polymorphisms and breast cancer risk in Chinese women. Oncotarget. 7(34). 55757–55764. 16 indexed citations
8.
Gao, Xueren, et al.. (2016). Serum 25-hydroxyvitamin D status in pregnant women with chronic hepatitis B virus infection. The Journal of Infection in Developing Countries. 10(8). 851–856. 6 indexed citations
9.
Zhang, Shulong, Xueren Gao, Yong Wang, et al.. (2015). Interleukin 27 -964A > G genetic polymorphism and serum IL-27p28 levels in Chinese patients with papillary thyroid cancer. Tumor Biology. 36(10). 8207–8211. 8 indexed citations
10.
Wang, Jie, Xueren Gao, Mingxi Wang, & Jianqiong Zhang. (2015). Clinicopathological significance and biological role of TCF21 mRNA in breast cancer. Tumor Biology. 36(11). 8679–8683. 20 indexed citations
11.
Gao, Xueren, Jie Wang, Wenjun Wang, Mingxi Wang, & Jianqiong Zhang. (2015). eNOS Genetic Polymorphisms and Cancer Risk. Medicine. 94(26). e972–e972. 27 indexed citations
12.
Gao, Xueren, Huiping Wang, Shulong Zhang, Mingxi Wang, & Zhansheng Zhu. (2015). Pri-miR-124 rs531564 polymorphism and colorectal cancer risk. Scientific Reports. 5(1). 14818–14818. 26 indexed citations
13.
Gao, Xueren, Shulong Zhang, Yao Yao, et al.. (2014). Association of cytotoxic T lymphocyte antigen-4 +49A/G polymorphism and cancer risk: An updated meta-analysis. Cancer Biomarkers. 14(4). 287–294. 11 indexed citations
14.
Ying, Hou‐Qun, Jie Wang, & Xueren Gao. (2014). CCL5-403, CCR5-59029, and Delta32 polymorphisms and cancer risk: a meta-analysis based on 20,625 subjects. Tumor Biology. 35(6). 5895–5904. 17 indexed citations
15.
Gao, Xueren, Shulong Zhang, & Zhansheng Zhu. (2014). Genetic variation of ErbB4 confers risk of colorectal cancer in a Chinese Han population. Cancer Biomarkers. 14(6). 435–439. 4 indexed citations
16.
Zhang, Shulong, et al.. (2014). Quantitative assessment of the associations between CD28 T > C polymorphism (rs3116496) and cancer risk. Tumor Biology. 35(9). 9195–9200. 7 indexed citations
17.
Zhu, Zhansheng, Xueren Gao, Yan He, et al.. (2012). An Insertion/Deletion Polymorphism within RERT-lncRNA Modulates Hepatocellular Carcinoma Risk. Cancer Research. 72(23). 6163–6172. 83 indexed citations
18.
Jiang, Lingling, Jingya Xu, Jianqiang Ni, et al.. (2012). A Functional Insertion/Deletion Polymorphism in the Proximal Promoter of CD3G Is Associated with Susceptibility for Hepatocellular Carcinoma in Chinese Population. DNA and Cell Biology. 31(9). 1480–1485. 7 indexed citations
19.
Yu, Qiang, Dayong Zhou, Lei Chen, et al.. (2012). The Mitochondrial DNA 9-bp Deletion Polymorphism Is a Risk Factor for Hepatocellular Carcinoma in the Chinese Population. Genetic Testing and Molecular Biomarkers. 16(5). 330–334. 16 indexed citations
20.
Jiang, Yuting, Shasha Jia, Zhansheng Zhu, et al.. (2011). Association of HLA-G 3′ UTR 14-bp Insertion/Deletion Polymorphism with Hepatocellular Carcinoma Susceptibility in a Chinese Population. DNA and Cell Biology. 30(12). 1027–1032. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luis Almonacid Breakdown of academic impact, for papers by Conny Blumert Breakdown of academic impact, for papers by Dawei Bu Breakdown of academic impact, for papers by Kayo Fujisawa Breakdown of academic impact, for papers by Jun Chi Breakdown of academic impact, for papers by Parvathi Ranganathan Breakdown of academic impact, for papers by Hongting Lu Breakdown of academic impact, for papers by Zhengyuan Yu Breakdown of academic impact, for papers by Wyne Lee Breakdown of academic impact, for papers by Sven Kroening
Rankless by CCL
2026